Saudi Arabia Pharmacy Retail Market By Market Structure (Organized, Unorganized), By Product Type (Prescribed Drugs, Over-the-Counter Products, Non-Pharmaceutical Products, Medical Equipment), By Therapeutic Area (Cardiovascular, Anti-Diabetic, Pain Relief/Analgesics, Vitamins/Minerals/Nutrients, Anti-Infective, Others), By Drug Type (Generic, Patented), By Pharmacy Location (Street/Mall Based, Hospital Based),By Region, Competition, Forecast & Opportunities, 2020-2030F
Market Overview
Saudi Arabia Pharmacy Retail market was valued at USD 7.34 Billion in 2024 and is expected to grow to USD 12.67 Billion by 2030 with a CAGR of 9.53%. The Saudi Arabia Pharmacy Retail market is primarily driven by several key factors, including the increasing demand for healthcare services, particularly due to the country's growing and aging population. Chronic diseases like diabetes, cardiovascular conditions, and respiratory illnesses are becoming more prevalent, leading to a higher demand for pharmaceutical products. As a part of this, according to a recent study, as of 2024, diabetes has emerged as a significant public health issue, with an estimated 18.5% of Saudi individuals having the disease. Also, government initiatives like Vision 2030 aim to improve the overall healthcare infrastructure, driving growth in the retail pharmacy sector. The rise in health awareness among consumers and a shift towards self-medication also contribute to market expansion. Also, the increasing availability of online pharmacies and e-commerce platforms further boosts the retail sector by providing convenient access to medicines and healthcare products. These combined factors position Saudi Arabia’s pharmacy retail market for sustained growth.
Key Market Drivers
Large Pool of People Suffering from Cardiovascular Disease
A large and growing pool of people suffering from cardiovascular diseases (CVD) is a significant driver of the Saudi Arabia pharmacy retail market. CVD, including heart disease and stroke, is increasingly prevalent due to lifestyle factors such as unhealthy diets, physical inactivity, and high smoking rates. As a part of this, according to a recent study, as of 2024, the prevalence of adult smoking in Saudi Arabia is 16.5%. There are 4,434,374 adult smokers in Saudi Arabia. In Saudi Arabia, 5.0% of young people smoke. As the population ages and adopts less healthy lifestyles, the demand for medications, over-the-counter products, and heart-related treatments rises, creating a substantial market for pharmacies. This demand is further fueled by the increased awareness of cardiovascular health and the growing focus on preventive care. Pharmacies in Saudi Arabia are playing a critical role in providing easy access to heart disease medications, supplements, and diagnostic products. Also, the government’s emphasis on improving healthcare services and tackling non-communicable diseases under Vision 2030 has enhanced pharmacy retail growth, making it a vital component in the nation’s healthcare landscape.
Key Market Challenges
Regulatory Complexities
Regulatory complexities pose a significant challenge to the Saudi Arabia pharmacy retail market. The pharmaceutical sector is heavily regulated, with strict laws governing the import, distribution, and sale of medicines. Retail pharmacies must comply with a wide range of regulations set by the Saudi Food and Drug Authority (SFDA), which can vary based on product categories, from over-the-counter drugs to prescription medicines and medical devices. Also, changing regulations and the approval process for new drugs can create uncertainty, causing delays in product availability and distribution. Compliance with these regulations can also lead to higher operational costs for pharmacies, especially when navigating import restrictions or managing inventory for regulated substances. Also, pharmacies must stay updated on evolving standards to avoid penalties and ensure consumer safety, making regulatory adherence a constant challenge in the highly competitive retail market.
Key Market Trends
Expansion of Online Pharmacies
The expansion of online pharmacies is a prominent trend in the Saudi Arabian pharmacy retail market, driven by increased consumer demand for convenience and accessibility. E-commerce platforms have become an essential channel for purchasing medications, health products, and wellness items, especially as consumers seek a seamless shopping experience. The COVID-19 pandemic accelerated this shift, as many consumers turned to online platforms for safety and convenience. Online pharmacies offer the advantage of home delivery, easy access to hard-to-find medications, and a broad range of health products, from over-the-counter drugs to dietary supplements. With growing trust in digital healthcare services, the market is witnessing more pharmacies adopting e-commerce models, partnering with logistics companies for efficient delivery, and integrating digital payment systems. This trend is expected to continue as consumers increasingly prioritize convenience, driving the growth of the online pharmacy sector in Saudi Arabia.
Key Market Players
In this report, the Saudi Arabia Pharmacy Retail Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies presents in the Saudi Arabia Pharmacy Retail Market.
Available Customizations:
Saudi Arabia Pharmacy Retail Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Saudi Arabia Pharmacy Retail market was valued at USD 7.34 Billion in 2024 and is expected to grow to USD 12.67 Billion by 2030 with a CAGR of 9.53%. The Saudi Arabia Pharmacy Retail market is primarily driven by several key factors, including the increasing demand for healthcare services, particularly due to the country's growing and aging population. Chronic diseases like diabetes, cardiovascular conditions, and respiratory illnesses are becoming more prevalent, leading to a higher demand for pharmaceutical products. As a part of this, according to a recent study, as of 2024, diabetes has emerged as a significant public health issue, with an estimated 18.5% of Saudi individuals having the disease. Also, government initiatives like Vision 2030 aim to improve the overall healthcare infrastructure, driving growth in the retail pharmacy sector. The rise in health awareness among consumers and a shift towards self-medication also contribute to market expansion. Also, the increasing availability of online pharmacies and e-commerce platforms further boosts the retail sector by providing convenient access to medicines and healthcare products. These combined factors position Saudi Arabia’s pharmacy retail market for sustained growth.
Key Market Drivers
Large Pool of People Suffering from Cardiovascular Disease
A large and growing pool of people suffering from cardiovascular diseases (CVD) is a significant driver of the Saudi Arabia pharmacy retail market. CVD, including heart disease and stroke, is increasingly prevalent due to lifestyle factors such as unhealthy diets, physical inactivity, and high smoking rates. As a part of this, according to a recent study, as of 2024, the prevalence of adult smoking in Saudi Arabia is 16.5%. There are 4,434,374 adult smokers in Saudi Arabia. In Saudi Arabia, 5.0% of young people smoke. As the population ages and adopts less healthy lifestyles, the demand for medications, over-the-counter products, and heart-related treatments rises, creating a substantial market for pharmacies. This demand is further fueled by the increased awareness of cardiovascular health and the growing focus on preventive care. Pharmacies in Saudi Arabia are playing a critical role in providing easy access to heart disease medications, supplements, and diagnostic products. Also, the government’s emphasis on improving healthcare services and tackling non-communicable diseases under Vision 2030 has enhanced pharmacy retail growth, making it a vital component in the nation’s healthcare landscape.
Key Market Challenges
Regulatory Complexities
Regulatory complexities pose a significant challenge to the Saudi Arabia pharmacy retail market. The pharmaceutical sector is heavily regulated, with strict laws governing the import, distribution, and sale of medicines. Retail pharmacies must comply with a wide range of regulations set by the Saudi Food and Drug Authority (SFDA), which can vary based on product categories, from over-the-counter drugs to prescription medicines and medical devices. Also, changing regulations and the approval process for new drugs can create uncertainty, causing delays in product availability and distribution. Compliance with these regulations can also lead to higher operational costs for pharmacies, especially when navigating import restrictions or managing inventory for regulated substances. Also, pharmacies must stay updated on evolving standards to avoid penalties and ensure consumer safety, making regulatory adherence a constant challenge in the highly competitive retail market.
Key Market Trends
Expansion of Online Pharmacies
The expansion of online pharmacies is a prominent trend in the Saudi Arabian pharmacy retail market, driven by increased consumer demand for convenience and accessibility. E-commerce platforms have become an essential channel for purchasing medications, health products, and wellness items, especially as consumers seek a seamless shopping experience. The COVID-19 pandemic accelerated this shift, as many consumers turned to online platforms for safety and convenience. Online pharmacies offer the advantage of home delivery, easy access to hard-to-find medications, and a broad range of health products, from over-the-counter drugs to dietary supplements. With growing trust in digital healthcare services, the market is witnessing more pharmacies adopting e-commerce models, partnering with logistics companies for efficient delivery, and integrating digital payment systems. This trend is expected to continue as consumers increasingly prioritize convenience, driving the growth of the online pharmacy sector in Saudi Arabia.
Key Market Players
- Nahdi Medical Company
- Tadawi Medical Center
- Atlas Pharmaceuticals
- CVS Health
- Walgreens Boots Alliance, Inc.
- Albertsons Companies, Inc.
- Rite Aid Corp.
- The Jean Coutu Group (PJC) inc.
- Loblaw Companies Limited
- MedPlus Health Services Limited
In this report, the Saudi Arabia Pharmacy Retail Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Saudi Arabia Pharmacy Retail Market, By Market Structure:
- Organized
- Unorganized
- Saudi Arabia Pharmacy Retail Market, By Product Type:
- Prescribed Drugs
- Over-the-Counter Products
- Non-Pharmaceutical Products
- Medical Equipment
- Saudi Arabia Pharmacy Retail Market, By Therapeutic Area:
- Cardiovascular
- Anti-Diabetic
- Pain Relief/Analgesics
- Vitamins/Minerals/Nutrients
- Anti-Infective
- Others
- Saudi Arabia Pharmacy Retail Market, By Drug Type:
- Generic
- Patented
- Saudi Arabia Pharmacy Retail Market, By Pharmacy Location:
- Street/Mall Based
- Hospital Based
- Saudi Arabia Pharmacy Retail Market, By Region:
- Eastern
- Western
- Northern & Central
- Southern
Company Profiles: Detailed analysis of the major companies presents in the Saudi Arabia Pharmacy Retail Market.
Available Customizations:
Saudi Arabia Pharmacy Retail Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. INTRODUCTION
1.1. Product Overview
1.2. Key Highlights of the Report
1.3. Market Coverage
1.4. Market Segments Covered
1.5. Research Tenure Considered
2. RESEARCH METHODOLOGY
2.1. Methodology Landscape
2.2. Objective of the Study
2.3. Baseline Methodology
2.4. Formulation of the Scope
2.5. Assumptions and Limitations
2.6. Sources of Research
2.7. Approach for the Market Study
2.8. Methodology Followed for Calculation of Market Size & Market Shares
2.9. Forecasting Methodology
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions
3.5. Overview of Market Drivers, Challenges, and Trends
4. VOICE OF CUSTOMER
4.1. Brand Awareness
4.2. Factor Influencing Availing Decision
5. SAUDI ARABIA PHARMACY RETAIL MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Market Structure (Organized, Unorganized)
5.2.2. By Product Type (Prescribed Drugs, Over-the-Counter Products, Non-Pharmaceutical Products, Medical Equipment)
5.2.3. By Therapeutic Area (Cardiovascular, Anti-Diabetic, Pain Relief/Analgesics, Vitamins/Minerals/Nutrients, Anti-Infective, Others)
5.2.4. By Drug Type (Generic, Patented)
5.2.5. By Pharmacy Location (Street/Mall Based, Hospital Based)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map
6. SAUDI ARABIA PRESCRIBED DRUGS PHARMACY RETAIL MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Market Structure
6.2.2. By Therapeutic Area
6.2.3. By Drug Type
6.2.4. By Pharmacy Location
7. SAUDI ARABIA OVER-THE-COUNTER PRODUCTS PHARMACY RETAIL MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Market Structure
7.2.2. By Therapeutic Area
7.2.3. By Drug Type
7.2.4. By Pharmacy Location
8. SAUDI ARABIA NON-PHARMACEUTICAL PRODUCTS PHARMACY RETAIL MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Market Structure
8.2.2. By Therapeutic Area
8.2.3. By Drug Type
8.2.4. By Pharmacy Location
9. SAUDI ARABIA MEDICAL EQUIPMENT PHARMACY RETAIL MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Market Structure
9.2.2. By Therapeutic Area
9.2.3. By Drug Type
9.2.4. By Pharmacy Location
10. MARKET DYNAMICS
10.1. Drivers
10.2. Challenges
11. MARKET TRENDS & DEVELOPMENTS
11.1. Merger & Acquisition (If Any)
11.2. Product Launches (If Any)
11.3. Recent Developments
12. PORTERS FIVE FORCES ANALYSIS
12.1. Competition in the Industry
12.2. Potential of New Entrants
12.3. Power of Suppliers
12.4. Power of Customers
12.5. Threat of Substitute Products
13. SAUDI ARABIA ECONOMIC PROFILE
14. POLICY & REGULATORY LANDSCAPE
15. COMPETITIVE LANDSCAPE
15.1. Company Profiles
15.1.1. Nahdi Medical Company
15.1.1.1. Business Overview
15.1.1.2. Company Snapshot
15.1.1.3. Products & Services
15.1.1.4. Financials (As Per Availability)
15.1.1.5. Key Market Focus & Geographical Presence
15.1.1.6. Recent Developments
15.1.1.7. Key Management Personnel
15.1.2. Tadawi Medical Center
15.1.3. Atlas Pharmaceuticals
15.1.4. CVS Health
15.1.5. Walgreens Boots Alliance, Inc.
15.1.6. Albertsons Companies, Inc.
15.1.7. Rite Aid Corp.
15.1.8. The Jean Coutu Group (PJC) inc.
15.1.9. Loblaw Companies Limited
15.1.10. MedPlus Health Services Limited
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Product Overview
1.2. Key Highlights of the Report
1.3. Market Coverage
1.4. Market Segments Covered
1.5. Research Tenure Considered
2. RESEARCH METHODOLOGY
2.1. Methodology Landscape
2.2. Objective of the Study
2.3. Baseline Methodology
2.4. Formulation of the Scope
2.5. Assumptions and Limitations
2.6. Sources of Research
2.7. Approach for the Market Study
2.8. Methodology Followed for Calculation of Market Size & Market Shares
2.9. Forecasting Methodology
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions
3.5. Overview of Market Drivers, Challenges, and Trends
4. VOICE OF CUSTOMER
4.1. Brand Awareness
4.2. Factor Influencing Availing Decision
5. SAUDI ARABIA PHARMACY RETAIL MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Market Structure (Organized, Unorganized)
5.2.2. By Product Type (Prescribed Drugs, Over-the-Counter Products, Non-Pharmaceutical Products, Medical Equipment)
5.2.3. By Therapeutic Area (Cardiovascular, Anti-Diabetic, Pain Relief/Analgesics, Vitamins/Minerals/Nutrients, Anti-Infective, Others)
5.2.4. By Drug Type (Generic, Patented)
5.2.5. By Pharmacy Location (Street/Mall Based, Hospital Based)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map
6. SAUDI ARABIA PRESCRIBED DRUGS PHARMACY RETAIL MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Market Structure
6.2.2. By Therapeutic Area
6.2.3. By Drug Type
6.2.4. By Pharmacy Location
7. SAUDI ARABIA OVER-THE-COUNTER PRODUCTS PHARMACY RETAIL MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Market Structure
7.2.2. By Therapeutic Area
7.2.3. By Drug Type
7.2.4. By Pharmacy Location
8. SAUDI ARABIA NON-PHARMACEUTICAL PRODUCTS PHARMACY RETAIL MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Market Structure
8.2.2. By Therapeutic Area
8.2.3. By Drug Type
8.2.4. By Pharmacy Location
9. SAUDI ARABIA MEDICAL EQUIPMENT PHARMACY RETAIL MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Market Structure
9.2.2. By Therapeutic Area
9.2.3. By Drug Type
9.2.4. By Pharmacy Location
10. MARKET DYNAMICS
10.1. Drivers
10.2. Challenges
11. MARKET TRENDS & DEVELOPMENTS
11.1. Merger & Acquisition (If Any)
11.2. Product Launches (If Any)
11.3. Recent Developments
12. PORTERS FIVE FORCES ANALYSIS
12.1. Competition in the Industry
12.2. Potential of New Entrants
12.3. Power of Suppliers
12.4. Power of Customers
12.5. Threat of Substitute Products
13. SAUDI ARABIA ECONOMIC PROFILE
14. POLICY & REGULATORY LANDSCAPE
15. COMPETITIVE LANDSCAPE
15.1. Company Profiles
15.1.1. Nahdi Medical Company
15.1.1.1. Business Overview
15.1.1.2. Company Snapshot
15.1.1.3. Products & Services
15.1.1.4. Financials (As Per Availability)
15.1.1.5. Key Market Focus & Geographical Presence
15.1.1.6. Recent Developments
15.1.1.7. Key Management Personnel
15.1.2. Tadawi Medical Center
15.1.3. Atlas Pharmaceuticals
15.1.4. CVS Health
15.1.5. Walgreens Boots Alliance, Inc.
15.1.6. Albertsons Companies, Inc.
15.1.7. Rite Aid Corp.
15.1.8. The Jean Coutu Group (PJC) inc.
15.1.9. Loblaw Companies Limited
15.1.10. MedPlus Health Services Limited
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
